Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announced the launch of its biomarker discovery service, ...
Dynamical systems modeling is one of the most successfully implemented methodologies throughout mathematical oncology (1). Applications of these model first approaches have led to important insights ...
TORONTO--(BUSINESS WIRE)--Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three ...
In a move that could reshape drug discovery, researchers at Harvard Medical School (HMS) have designed an artificial intelligence (AI) model they say is capable of identifying treatments that reverse ...
In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells ...
with insights into Evotec and our capabilities. This edition features Evotec’s PanOmics-driven drug discovery approach, the impact of precision medicine approaches, and the software platform PanHunter ...
Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results